Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Cystic Fibrosis
Interventions
DRUG

sodium chloride (7%)

4mL nebulized 7% sodium chloride

Trial Locations (2)

21287

Johns Hopkins University, Baltimore

27516

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER